An interventional study of AUD treatment sessions with an outreach alcohol therapist at the hospital and Guidance and leaflet on AUD treatment facilities outside the hospital in Alcohol Use Disorder, sponsored by Zealand University Hospital. Recruiting at 1 site in Denmark. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Zealand University Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 29 studies in Alcoholism with a site in Denmark — 7 open to participants now, 11 under way, none of them phase 3. Alcoholism · Denmark.
Among the 29 studies in Alcoholism with a site in Denmark, this one is the 19th largest by planned enrollment, is the only one that started in 2026, is one of 17 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 28th registered.
1,679 studies on the registry are indexed under Alcoholism; 333 are open to participants now.
Browse Alcoholism studies →7 of the 29 studies in Alcoholism with a site in Denmark are open now. Recruiting first, the newest first:
Zealand University Hospital · Sites in Denmark
Ages 18+
Anders Fink-Jensen, MD, DMSci · Sites in Denmark
Ages 30–65
Anders Fink-Jensen, MD, DMSci · Sites in Denmark
Ages 18–70
Nina Kimer · Sites in Denmark
Ages 18+
Zealand University Hospital · Sites in Denmark
Ages 18–110
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 238 Alcoholism studies recruiting now, 85 (36%) set no upper age limit and 131 (55%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.
This study: 18 Years to 99 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
29 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 88 across 1,433 interventional studies indexed under Alcoholism.
Median enrollment 113 across the 29 interventional studies. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 29 has an industry lead sponsor. The 10 most frequent:
Zealand University Hospital is the lead sponsor of 237 studies on the registry; 50 are open to participants now.
Zealand University Hospital has 3 studies filed under Alcoholism — fewer than ten, so there is no comparison to draw.
1 of the studies in Alcoholism with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07482150Zealand University HospitalThe Connect Trial: Connecting Hospital Patients to Alcohol Care | 2027-09-01 |
Add it to your calendar (.ics) → With an account.
Among the 29 studies in Alcoholism with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The main objective of this pilot study is to assess feasibility of conducting a definitive RCT with concealed allocation, blinded outcome assessment and a 1:1 parallel group design of A) an invitation to meet an AUD therapist for up to 10 treatment sessions at the hospital in up to 6 months (intervention) compared to B) guidance on how to seek alcohol care in an AUD treatment centre in the community, outside of the hospital (control).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants randomised as controls will be offered a leaflet informing about different possibilities for alcohol misuse treatments and guidance on how to approach them (may include referral or help with doing an appointment, if possible according to the specific treatment center) in the catchment area of SUH Køge and Roskilde.
Other: Guidance and leaflet on AUD treatment facilities outside the hospital
Participants will be offered an AUD treatment session at the hospital the same or next day as they are enrolled in the study with an outreach alcohol therapist from a local AUD treatment facility. The alcohol therapist will be trained in motivational interviewing and cognitive behavioural therapy for AUD. The session will last for 20 to 60 minutes and can take place either at the department where the patient is admitted or elsewhere to ensure confidentiality. Up to 10 sessions at the hospital during 6 months after the baseline visit can be offered and after that, the participant can continue to meet with the same therapist in the community alcohol treatment facility. The participant will also be informed about other options for specialised alcohol treatment, group therapy, peer support and self-help groups.
Other: AUD treatment sessions with an outreach alcohol therapist at the hospital
Participants will be offered an AUD treatment session at the hospital the same or next day as they are enrolled in the study with an outreach alcohol therapist from a local AUD treatment facility. The alcohol therapist will be trained in motivational interviewing and cognitive behavioural therapy for AUD. The session will aim to motivate patients to reduce their alcohol consumption and set goals for AUD treatment. The alcohol therapist can recommend a medical therapy to support alcohol reduction or abstinence - this prescription will be undertaken by a hepatologist from the Department of Medicine and may be continued after discharge by patients´ general practitioner or physicians at the AUD treatment facility. Up to 10 sessions of up to 60 minutes of duration at the hospital during 6 months after the baseline visit can be offered and after that, the participant can continue to meet with the same therapist in the community.
Participants randomised as controls will be offered a leaflet informing about different possibilities for alcohol misuse treatments and guidance on how to approach them (may include referral or help with doing an appointment, if possible according to the specific treatment center) in the catchment area of SUH Køge and Roskilde
Recruitment
\>50% of eligible individuals invited to the study give written informed consent
Time frame: 6 months
Retention
\>50% individuals recruited and randomized to the intervention, will attend to the intervention of seing the AUD therapist at least once
Time frame: 6 months
Completion
\>50% of all randomized study participants complete the follow-up interview and blood sample
Time frame: 6 months
AUD treatment engagement after 6 and 12 months
No predefined goal
Time frame: 12 months
Mortality after 6 and 12 months
No predefined goal
Time frame: 12 months
Change in drinks (containing 12 g ethanol) per last 30 days from baseline till 6 months after inclusion
Time frame: 6 months
Proportion with abstinence or light drinking (<10 drinks/week) last 30 days
yes or no
Time frame: 6 months
Change in blood phosphatidyl ethanol level from baseline to 6 months after inclusion
Time frame: 6 months
Change in motivation to cut down on alcohol (yes or no), calculated as the difference between baseline and 6 months follow-up
Time frame: 6 months
Number of AUD treatment sessions
Time frame: 6 months
Proportion initiating medical AUD therapy
Time frame: 6 months
Proportion receiving medical AUD treatment at 6- and 12 months follow up
Time frame: 12 months
Number of acute hospital admissions or emergency room visits at 6 and 12 months
Time frame: 12 months
Number of hospital outpatient visits at 6 and 12 months
Time frame: 12 months
3- year follow-up, conducted through health care registries and AUD treatment facilities to look for incidence of alcohol-related morbidity and mortality, visits to general practitioner and hospital contacts
Time frame: 3 years
Plan to share: No
Started Mar 2026 (actual). Primary completion is estimated for Sep 2027, 17 months after the start.
Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's planned 17 months is below that.
Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.